Re $GILD- From the middle of March - My current guess is for $2.80/sh (vs. ~$2.28 current consensus) and $4.4B sales of HCV scripts. $2.80/sh of earnings results in about $9.40/sh of TTM earnings. Again, the amount of OUS HCV sales is the largest unknown. https://finance.yahoo.com/news/gilead-sciences-announces-first-quarter-200100723.html Not bad. OUS was even a little higher than I thought and FX didn't hurt as much as I thought. Let's see what issues come up on the call.